Back to Agenda
Session 5, Track B: Challenges, Opportunities, and Best Practices in Pharmacovigilance in the LATAM (Part I)
Session Chair(s)
Gislaine Villarta Capeleti Dib, PharmD
Operational Manager
PGA Farma, Brazil
Maria Victoria Abdala, MHS, RPh, RAC
Director, Pharmacovigilance (PV) Cluster Lead - LA South
MSD, Argentina
This session will offer participants insights into the key challenges affecting Pharmacovigilance practices in the LATAM region, informed by recent global updates. We will explore opportunities for enhancement based on global regulatory changes and review the best practices from successful global PV initiatives applicable to LATAM. Participants will engage with global experts and industry representatives to foster collaboration and drive improvements in Pharmacovigilance across the region.
Learning Objective : - Identify key challenges in LATAM Pharmacovigilance activities based on recent global initiatives
- Explore opportunities for enhancing PV practices in LATAM, informed by global regulatory landscape changes
- Discuss best practices from global PV initiatives applicable to the LATAM context
Speaker(s)
CIOMS XII: Structured Benefit Risk Framework: A Strategic Lifecycle Approach
Carmit Strauss, PharmD
Takeda, United States
Executive Director, Head of Risk Management, Organ Toxicity and Benefit Risk
Modernizing ICSR Management: A Model for Meaningful Multi-Stakeholder Dialogue
Patrice Wright, PhD, PMP
TransCelerate BioPharma Inc., United States
Health Authority Engagement Director
Pharmacovigilance in Latin America - Updates, Advances, and Challenges
Salvador Alvarado Lopez, MD, MPH, MSc
Uppsala Monitoring Centre, Sweden
Regional Pharmacovigilance Manager
Have an account?